WS #12221
Abbott raised 2026 EPS outlook; State Street beat earnings; Crypto.com $20B valuation; Merck Lipfendra FDA approval. US grocery units sold down 1.8% YoY in June, pressured by 20% gas price spike; consumer stretched.
Positive Corporate Earnings/Developments
Abbott raised 2026 EPS outlook; State Street beat earnings; Crypto.com $20B valuation; Merck Lipfendra FDA approval.
US grocery units sold down 1.8% YoY in June, pressured by 20% gas price spike; consumer stretched.